A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Clinical Team
Deciphera Pharmaceuticals, LLC
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Aarhus University Hospital
Aarhus, Denmark
Ninna Aggerholm Pedersen, MDRecruiting
- Centre Oscar Lambret
Lille, France
Loic Lebellec, MDRecruiting - Hôpital Européen Georges Pompidou
Paris, France
Widad Lahlou, MDRecruiting
- Universitatsklinikum Franfurt
Frankfurt, Germany
Marit Ahrens, MDRecruiting - Universitätsklinikum Eppendorf
Hamburg, Germany
Jana Striefler, MDRecruiting
- Aou Careggi - Padiglione 16 - Piano Terra - Ambulatori Oncologici - Ufficio Trial
Florence, Italy
Lorenzo Antonuzzo, MDRecruiting - Irccs Azienda Ospedaliera Metropolitana
Genova, Italy
Danila Comandini, MDRecruiting - Istituto Europeo Di Oncologia
Milan, Italy
Elisabetta Setola, MDRecruiting
- Antonie Van Leeuwenhoek Hospital
Amsterdam, Netherlands
Neeltje Steeghs, MDRecruiting - Radboudumc
Nijmegen, Netherlands
Ingrid Desar, MDRecruiting
- Instituto Português de Oncologia Do Porto Francisco Gentil, E.P.E.
Porto, Portugal
Miguel Abreu, MDRecruiting
- Hospital Universitario Clinico San Carlos
Madrid, Spain
Gloria Marquina Ospina, MDRecruiting - Hospital Universitario Ramón Y Cajal
Madrid, Spain
Maria Angeles Vaz Salgado, MDRecruiting - Hospital Universitario Virgen del Rocio
Seville, Spain
Maria Pilar Sancho Marquez, MDRecruiting
- Inselspital Universitätsklinikum Bern
Bern, Switzerland
Attila Kollar, MDRecruiting
- Ucla Department of Medicine-Hematology/oncology
Los Angeles, California, United States
Arun Singh, MDRecruiting - University of Southern California - Norris Comprehensive Cancer Center
Los Angeles, California, United States
Syma Iqbal, MDRecruiting - Sylvester Comprehensive Cancer Center
Miami, Florida, United States
Jonathan C Trent, MD, PhDRecruiting - University of Massachusetts Worcester
Worcester, Massachusetts, United States
Recruiting - Start Midwest
Grand Rapids, Michigan, United States
Sreenivasa Chandana, M.D., Ph.D.Recruiting - Washington University School of Medicine - Siteman Cancer Center
St Louis, Missouri, United States
Mia Weiss, MDRecruiting - Memorial Sloan Kettering Cancer Center - Main Campus
New York, New York, United States
Ping Chi, MD, PhDRecruiting - Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
Recruiting - Oregon Health & Science University
Portland, Oregon, United States
Recruiting - Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
Margaret von Mehren, MDRecruiting - Virginia Cancer Specialist, Pc
Fairfax, Virginia, United States
Chao Yin, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Sept 2023
- Primary completion
- 31 Mar 2027
- Completion
- 31 Mar 2029
- Last update posted
- 2 Jun 2026
- Registered enrollment
- 94
- Registry id
- NCT05957367
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.